Literature DB >> 16325619

Safety and efficacy of cytoreductive surgery for epithelial ovarian cancer in elderly and high-risk surgical patients.

Sameer Sharma1, Deborah Driscoll, Kunle Odunsi, Arun Venkatadri, Shashikant Lele.   

Abstract

OBJECTIVE: Surgery is the cornerstone of management in ovarian cancer. However, in high-risk and elderly patients there is a tendency for less aggressive surgery upfront. The aim of this study was to review cytoreductive surgery, with focus on complications and outcomes in patients with multiple surgical risk factors. STUDY
DESIGN: Charts of patients with ovarian cancer from 1998 to 2002 were retrospectively reviewed.
RESULTS: One hundred and forty patients were treated for ovarian cancer. Sixty-three patients (45%) were elderly (> or =65 years), and 69 patients (49%) had comorbidities. Optimal debulking (< or =1 cm) was achieved in 123 patients (88%). There was no significant relation between complications and type of procedure, elderly age, comorbidities, or transfusions. Optimally debulked patients had a significantly longer survival than patients with suboptimal debulking (P < .001).
CONCLUSION: Aggressive optimal cytoreduction can be achieved in the majority of patients with multiple surgical risk factors and is associated with a low complication rate.

Entities:  

Mesh:

Year:  2005        PMID: 16325619     DOI: 10.1016/j.ajog.2005.06.074

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  10 in total

1.  In Pursuit of Optimal Cytoreduction in Ovarian Cancer Patients: The Role of Surgery and Surgeon.

Authors:  Lele Shashikant; P Kesterson Joshua
Journal:  J Obstet Gynaecol India       Date:  2009 May-Jun

2.  Factors predicting postoperative morbidity after cytoreductive surgery for ovarian cancer: a systematic review and meta-analysis.

Authors:  Malika Kengsakul; Gatske M Nieuwenhuyzen-de Boer; Suwasin Udomkarnjananun; Stephen J Kerr; Christa D Niehot; Heleen J van Beekhuizen
Journal:  J Gynecol Oncol       Date:  2022-06-07       Impact factor: 4.756

3.  Feasibility and safety of extensive upper abdominal surgery in elderly patients with advanced epithelial ovarian cancer.

Authors:  Myong Cheol Lim; Sokbom Kang; Yong Jung Song; Sae Hyun Park; Sang-Yoon Park
Journal:  J Korean Med Sci       Date:  2010-06-17       Impact factor: 2.153

4.  Risk-scoring model for prediction of non-home discharge in epithelial ovarian cancer patients.

Authors:  Mariam M AlHilli; Christine W Tran; Carrie L Langstraat; Janice R Martin; Amy L Weaver; Michaela E McGree; Andrea Mariani; William A Cliby; Jamie N Bakkum-Gamez
Journal:  J Am Coll Surg       Date:  2013-06-29       Impact factor: 6.113

Review 5.  Ovarian cancer cytoreductive surgery in the elderly.

Authors:  Ginger J Gardner
Journal:  Curr Treat Options Oncol       Date:  2009-08

Review 6.  Considerations in the surgical management of ovarian cancer in the elderly.

Authors:  Carrie Langstraat; William A Cliby
Journal:  Curr Treat Options Oncol       Date:  2013-03

7.  Age is associated with prognosis in serous ovarian carcinoma.

Authors:  Fei Deng; Xia Xu; Mengmeng Lv; Binhui Ren; Yan Wang; Wenwen Guo; Jifeng Feng; Xiaoxiang Chen
Journal:  J Ovarian Res       Date:  2017-06-12       Impact factor: 4.234

8.  The impact of comorbidity and stage on ovarian cancer mortality: a nationwide Danish cohort study.

Authors:  Mette S Tetsche; Claus Dethlefsen; Lars Pedersen; Henrik T Sorensen; Mette Norgaard
Journal:  BMC Cancer       Date:  2008-01-29       Impact factor: 4.430

Review 9.  The Application and Outcome of Standard of Care Treatment in Elderly Women with Ovarian Cancer: A Literature Review over the Last 10 Years.

Authors:  Steven J Gibson; Gini F Fleming; Sarah M Temkin; Dana M Chase
Journal:  Front Oncol       Date:  2016-03-24       Impact factor: 6.244

Review 10.  Ovarian Cancer Management in the Oldest Old: Improving Outcomes and Tailoring Treatments.

Authors:  Lucia Tortorella; Giuseppe Vizzielli; Domenico Fusco; William C Cho; Roberto Bernabei; Giovanni Scambia; Giuseppe Colloca
Journal:  Aging Dis       Date:  2017-10-01       Impact factor: 6.745

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.